Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EP547 for cholestatic pruritus in primary biliary cholangitis or primary sclerosing cholangitis
NL-OMON53412Phase 2Completed
- Sponsor
- Escient Pharmaceuticals
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cholestatic pruritus comparing EP547 with Placebo (2 arms). Primary endpoint: Change in weekly average Worst Itch Numeric Rating Scale. Started Apr 2024; status: completed.
02
Drugs
EP547
03
Conditions
cholestatic pruritus
Beyond the preview
Go deeper on NL-OMON53412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53412.